Clinical Trials Directory

Trials / Completed

CompletedNCT04400500

Differential Diagnosis and Risk Stratification in Patients With Suspected NSTEACS

Approaches to Differential Diagnosis and Risk Stratification in Patients Hospitalized With Suspected Acute Coronary Syndrome Without Persistent ST-segment Elevation

Status
Completed
Phase
Study type
Observational
Enrollment
140 (actual)
Sponsor
National Research Center for Preventive Medicine · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To evaluate possibilities of rapid differential diagnosis and risk stratification in patients urgently admitted to the CCU with a suspected acute coronary syndrome without persistent ST-segment elevation (NSTEACS).

Detailed description

Single centre prospective non-randomised non-comparative study of patients delivered by ambulance and admitted to the CCU with suspected NSTEACS. Aims of this study are: 1. To characterize the contingent of patients admitted to the CCU with suspected NSTEACS. 2. To evaluate possibilities of fast differential diagnosis and risk stratification in patients admitted to the CCU with suspected NSTEACS using clinical data, ECG, biomarker levels (hsTn, NT-proBNP, hsCPR, cardiac FABP) as well as HEART, ADAPT, EDACS, T-MACS, GRACE, ACTION and TIMI scores. 3. To evaluate the correlation between clinical data, ECG, biomarker levels (hsTn, NT-proBNP, hsCPR, cardiac FABP) as well as HEART, ADAPT, EDACS, T-MACS, GRACE, ACTION and TIMI scores with presence and severity of coronary atherosclerosis in patients admitted to the CCU (intensive care unit) with suspected NSTEACS.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTApproaches to differential diagnosis and risk stratificationDetailed analysis of clinical course, ECG, biomarkers (hsTn I, CK-MB mass, myoglobin, NT-proBNP, hsCPR, cardiac FABP on admission and after 3 hours; hsTn I, CK-MB mass and myoglobin after 6 hours if needed) as well as HEART, ADAPT, EDACS, T-MACS, GRACE, ACTION and TIMI scores.

Timeline

Start date
2020-03-01
Primary completion
2023-11-30
Completion
2023-11-30
First posted
2020-05-22
Last updated
2023-12-11

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT04400500. Inclusion in this directory is not an endorsement.